Order Article Reprints

Alserawan L, Mulet M, Anguera G, Riudavets M, Zamora C, Osuna-Gómez R, Serra-López J, Barba Joaquín A, Sullivan I, Majem M, et al. Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors. Cancers. 2024; 16(9):1759. https://doi.org/10.3390/cancers16091759

Alserawan, Leticia, Maria Mulet, Geòrgia Anguera, Mariona Riudavets, Carlos Zamora, Rubén Osuna-Gómez, Jorgina Serra-López, Andrés Barba Joaquín, Ivana Sullivan, Margarita Majem, and et al. 2024. "Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors" Cancers 16, no. 9: 1759. https://doi.org/10.3390/cancers16091759

Alserawan, L., Mulet, M., Anguera, G., Riudavets, M., Zamora, C., Osuna-Gómez, R., Serra-López, J., Barba Joaquín, A., Sullivan, I., Majem, M., & Vidal, S. (2024). Kinetics of IFNγ-Induced Cytokines and Development of Immune-Related Adverse Events in Patients Receiving PD-(L)1 Inhibitors. Cancers, 16(9), 1759. https://doi.org/10.3390/cancers16091759